FDA Inspection 1269574 — Nanogen Co.,Ltd.

Nanogen Co.,Ltd. — FEI 3014653467

The FDA completed an inspection of Nanogen Co.,Ltd. on Feb 21, 2025 in Ansan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ansan (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.